GO:0005507 copper ion binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005507 (copper ion binding) is a molecular function defined as binding to a copper (Cu) ion, with synonyms copper binding and copper/cadmium binding.
• Copper is bound by diverse proteins including α-synuclein, αB-crystallin, cupredoxin-fold proteins, periplasmic chaperones such as SilF, porin P1 precursor fragments, and metalloproteomes detected by CysMP.
• Copper binding can drive amyloid formation, modulate chaperone metal selectivity, catalyze norovirus inactivation, and regulate glycolytic enzyme activity.
• Potassium homeostasis and histidine-rich surface ligands influence copper ion binding to human αB-crystallin and branched MAP-type ligands.
• Copper ion binding is studied using structural biology, metalloproteomics, spectroscopy, and CRISPR-based gene editing models.
• Dysregulated copper binding is linked to neurodegeneration, cancer metabolism, and infectious disease processes.
Description
Copper ion binding (GO:0005507) is a molecular function that describes the selective interaction of a protein or biomolecule with a copper (Cu) ion. Copper is an essential trace element that can exist in oxidized Cu(II) and reduced Cu(I) states, and proteins that bind copper exploit this redox flexibility for catalysis, electron transfer, metal transport, and structural stabilization. The QuickGO definition states that this term represents binding to a copper (Cu) ion, and its synonyms include copper binding and copper/cadmium binding. Because copper is both essential and potentially toxic, the proteins that bind it are central to cellular metal homeostasis and to a wide range of physiological and pathological processes. Researchers study copper ion binding to understand how metalloproteins acquire, retain, and utilize copper, and how disruption of these interactions contributes to disease. The breadth of the term is illustrated by proteins as different as α-synuclein, αB-crystallin, cupredoxin-fold electron carriers, the SilF periplasmic chaperone, and porin P1 precursor fragments, all of which engage copper ions through distinct structural strategies. In this article we synthesize authoritative QuickGO annotation data with real PubMed literature to provide a research-grade overview of copper ion binding, its mechanisms, associated genes, disease relevance, and the experimental methods used to study it.
copper ion binding At A Glance
| GO ID | GO:0005507 |
|---|---|
| GO term | copper ion binding |
| Ontology | molecular_function |
| Synonym | copper binding; copper/cadmium binding |
| Definition | Binding to a copper (Cu) ion. |
| Major function | Selective coordination of Cu(I) or Cu(II) for transport, catalysis, electron transfer, or structural roles |
| Representative proteins | α-synuclein, αB-crystallin, cupredoxin-fold proteins, SilF, porin P1 precursor fragments, PGK1 |
| Related metal ions | Cu(I), Cu(II); cadmium can compete at some sites |
| Common binding residues | Histidine, cysteine, methionine |
| Research areas | Neurodegeneration, cancer metabolism, infectious disease, metalloproteomics |
What Is GO:0005507?
In our own words, GO:0005507 (copper ion binding) is the molecular function of selectively and non-covalently interacting with a copper ion (Cu). It is a child of metal ion binding and encompasses proteins that coordinate Cu(I) or Cu(II) through side chains such as histidine, cysteine, and methionine, as well as through backbone atoms or cofactors. The term is agnostic to the downstream biological outcome: a copper-binding protein may transport, store, sense, catalyze with, or be regulated by copper. The QuickGO synonyms copper binding and copper/cadmium binding reflect the fact that some copper-binding sites can also accommodate cadmium, a toxic metal that can compete with copper.
Why Is copper ion binding Important in Cell Biology?
Copper ion binding is fundamentally important because copper is a redox-active transition metal that must be delivered to specific proteins without generating toxic reactive oxygen species. Proteins annotated with GO:0005507 control copper-dependent processes ranging from electron transfer in cupredoxin-fold proteins to amyloid formation by α-synuclein and metal-specific regulation of glycolysis. The same term also captures host-pathogen interactions, such as copper-catalyzed inactivation of human norovirus and copper binding by bacterial periplasmic chaperones and porin fragments. Because copper homeostasis intersects with neurodegeneration, cancer, and infection, understanding copper ion binding at the structural and cellular level is a high-priority research goal.
• Copper ion binding enables redox chemistry in enzymes and electron-transfer proteins with cupredoxin folds.
• It underlies amyloid formation by α-synuclein, a process relevant to Parkinson's disease and other synucleinopathies.
• It modulates the chaperone function of human αB-crystallin, with potassium homeostasis influencing copper binding.
• It is exploited by bacterial periplasmic chaperones such as SilF for silver/copper resistance.
• It can catalyze the inactivation of human norovirus, linking copper binding to antiviral mechanisms.
• It regulates glycolytic enzyme activity, as shown for PGK1 in metalloproteomic studies.
• It is a target of cadmium competition, making copper-binding sites sensitive to toxic metal exposure.
• It is studied using metalloproteomics tools such as CysMP that reveal metal ion-specific proteomes.
• It contributes to DNA degradation when copper-bound porin P1 precursor fragments are present.
• It is a key parameter in designing metal-binding ligands and metallodrugs.
Molecular Mechanism of copper ion binding
Copper coordination chemistry
In simple terms: Copper sticks to proteins through specific atoms, much like a key fitting a lock.
Copper ion binding relies on coordination chemistry in which Cu(I) or Cu(II) is held by electron-donating atoms from amino acid side chains. Histidine, cysteine, and methionine are common ligands, and the geometry and oxidation state of the copper ion determine binding affinity and reactivity. Branched MAP-type ligands with histidine surface functionalities have been used to model Cu(II) and Zn(II) binding, showing that histidine-rich environments can discriminate between metal ions. The cupredoxin fold is a classic copper-binding scaffold that positions copper for electron transfer, and variations on this fold tune the reduction potential and substrate specificity of copper proteins.
Copper incorporation into amyloid assemblies
In simple terms: Copper can become part of the sticky protein clumps seen in neurodegenerative diseases.
α-Synuclein, a protein central to Parkinson's disease, binds copper ions, and copper incorporation into α-synuclein amyloids has been structurally characterized. This incorporation can influence amyloid morphology and stability, providing a direct link between copper ion binding and neurodegeneration. The presence of copper within amyloid fibrils suggests that metal binding is not merely a transient interaction but can be a structural component of the aggregated state.
Metal-specific chaperones and periplasmic binding
In simple terms: Some bacteria use special proteins to grab copper and related metals before they become toxic.
The periplasmic chaperone SilF binds Ag(I) and Cu(I) with an adaptable ion-binding site, illustrating how copper ion binding can be tuned for metal selectivity and resistance. Porin P1 precursor fragments from Fusobacterium nucleatum bind Cu(II), and this binding affects DNA degradation, linking copper binding to bacterial virulence-associated activities. These examples show that copper ion binding is not limited to eukaryotic metalloproteins but is also a key feature of bacterial metal handling.
Copper-catalyzed inactivation of pathogens
In simple terms: Copper can help destroy viruses by generating damaging chemicals.
Copper ion-catalyzed inactivation of human norovirus has been demonstrated, with mechanisms involving copper-mediated oxidative damage to viral capsids or genomes. This antiviral activity depends on copper ion binding and redox cycling, and it provides a rationale for copper-based antimicrobial surfaces and therapeutics. The study highlights how the same copper-binding chemistry that supports normal physiology can be harnessed to inactivate pathogens.
Regulation of copper binding by cellular ions and metalloproteomes
In simple terms: Other ions and proteins in the cell can change how tightly copper binds.
Potassium homeostasis influences copper ion binding to human αB-Crystallin, indicating that the ionic environment modulates copper-protein interactions. Metalloproteomic profiling with CysMP has revealed metal ion-specific metalloproteomes and copper-regulated PGK1 activity in glycolysis, showing that copper binding can directly affect metabolic enzyme function. These findings underscore that copper ion binding is a dynamic process regulated by cellular ion balance and by the availability of competing metals such as cadmium.
Key Genes Involved in GO:0005507 copper ion binding
The following genes and proteins represent major copper-binding factors and related metalloproteins discussed in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SNCA | α-Synuclein binds copper and incorporates it into amyloids | Parkinson's disease and synucleinopathy models |
| CRYAB | αB-Crystallin binds copper; potassium homeostasis affects binding | Chaperone biology and protein aggregation |
| SILF | Periplasmic chaperone with adaptable Ag(I)/Cu(I) binding site | Bacterial metal resistance |
| PGK1 | Glycolytic enzyme with copper-regulated activity | Cancer metabolism and metalloproteomics |
| CUP1 | Yeast copper-binding metallothionein (cupredoxin-related copper handling) | Model for copper homeostasis |
| ATOX1 | Copper chaperone delivering copper to ATPases | Copper trafficking |
| ATP7A | Copper-transporting ATPase with copper-binding domains | Menkes disease and copper transport |
| ATP7B | Copper-transporting ATPase with copper-binding domains | Wilson disease and copper transport |
| SOD1 | Cu/Zn superoxide dismutase binds copper for antioxidant defense | ALS and oxidative stress |
| MT1A | Metallothionein binds copper and other metals | Metal detoxification |
| MT2A | Metallothionein binds copper and other metals | Metal detoxification |
| P1 | Porin P1 precursor fragments bind Cu(II) | Bacterial DNA degradation and virulence |
| CysMP targets | Metalloproteins detected by CysMP profiling | Metal ion-specific proteomics |
| Norovirus capsid proteins | Targets of copper-catalyzed inactivation | Antiviral copper mechanisms |
| MAP-type ligands | Synthetic branched ligands with histidine surface groups | Modeling Cu(II)/Zn(II) binding |
| Cupredoxin-fold proteins | Electron transfer proteins with copper centers | Bioinorganic chemistry and enzymology |
| αB-Crystallin | Small heat shock protein with copper-binding capacity | Protein stability and disease |
How Is copper ion binding Regulated?
Copper ion binding is regulated at multiple levels. Cellular potassium homeostasis modulates copper binding to human αB-Crystallin, indicating that ion balance directly affects copper-protein interactions. Metal competition, such as cadmium competing for copper-binding sites, can alter the occupancy and function of copper proteins. Metalloproteomic studies show that copper availability regulates specific metalloproteomes and can modulate enzyme activity, as seen for PGK1 in glycolysis. In bacteria, periplasmic chaperones like SilF adapt their binding sites to handle different metal ions, providing a regulatory mechanism for metal resistance.
copper ion binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SNCA | Parkinson's disease; amyloid formation | Knockout and point-mutation models of copper-binding residues |
| CRYAB | Protein aggregation; chaperone dysfunction | Knock-in of copper-binding site variants |
| PGK1 | Cancer metabolism; glycolysis | Overexpression and knockout in cancer cell lines |
| SILF | Bacterial metal resistance | Bacterial knockout and complementation |
| Norovirus capsid | Viral inactivation by copper | In vitro copper inactivation assays |
Neurodegeneration and α-synuclein copper binding
Copper ion binding to α-synuclein and its incorporation into amyloids is directly relevant to Parkinson's disease and other synucleinopathies. The structural characterization of copper-containing α-synuclein amyloids suggests that copper may influence the formation, stability, and toxicity of protein aggregates. This has motivated research into copper chelation and metal-modulating therapies for neurodegenerative diseases.
Cancer metabolism and copper-regulated enzymes
Metalloproteomic profiling has revealed copper-regulated PGK1 activity in glycolysis, linking copper ion binding to metabolic reprogramming in cancer cells. Because glycolytic enzymes are often upregulated in tumors, copper-dependent regulation of PGK1 may represent a targetable vulnerability. This connection places copper ion binding at the intersection of metal homeostasis and cancer metabolism.
Infectious disease and copper-based antimicrobials
Copper ion-catalyzed inactivation of human norovirus demonstrates that copper binding can be harnessed to damage pathogens. Bacterial copper-binding proteins such as SilF and porin P1 precursor fragments contribute to metal resistance and virulence-associated DNA degradation. These findings support the development of copper-based antimicrobial strategies and the study of bacterial copper homeostasis as a therapeutic target.
Metal toxicity and cadmium competition
Cadmium can compete with copper for binding sites, as shown in studies of branched histidine-containing ligands. This competition can disrupt copper-dependent processes and contribute to metal toxicity. Understanding the structural basis of copper versus cadmium binding is therefore important for toxicology and for designing selective metal-binding compounds.
From copper ion binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does copper binding to α-synuclein drive amyloid formation? | SNCA knockout and point-mutation knock-in cell models |
| How does potassium homeostasis affect copper binding to αB-crystallin? | CRYAB knockout and overexpression models |
| Does copper regulate PGK1 activity in glycolysis? | PGK1 knockout and overexpression in cancer cells |
| How do bacteria adapt copper-binding sites for metal resistance? | SILF knockout and complementation in bacteria |
| Can copper-catalyzed inactivation be enhanced against norovirus? | In vitro norovirus capsid models |
| How do histidine-rich ligands discriminate copper from cadmium? | Synthetic ligand and point-mutation models |
How to Study the copper ion binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| X-ray crystallography | Atomic structure of copper-binding sites | Cupredoxin and chaperone structures |
| NMR spectroscopy | Copper coordination and dynamics | α-Synuclein and small proteins |
| CysMP metalloproteomics | Metal ion-specific proteomes | Copper-regulated PGK1 discovery |
| UV-visible spectroscopy | Copper redox and ligand-to-metal charge transfer | Cu(II)/Cu(I) binding studies |
| Isothermal titration calorimetry | Binding affinity and thermodynamics | αB-Crystallin copper binding |
| Amyloid formation assay | Fibril formation and copper incorporation | α-Synuclein aggregation |
| Viral inactivation assay | Loss of viral infectivity | Norovirus copper inactivation |
| DNA degradation assay | Nuclease activity of copper-bound proteins | Porin P1 precursor fragments |
Structural biology of copper binding
X-ray crystallography, NMR, and cryo-EM are used to determine how copper ions are coordinated within proteins and amyloids. These methods reveal binding-site geometry, oxidation state preferences, and conformational changes upon copper binding. Structural insights guide the design of point mutations that abolish or enhance copper binding.
Metalloproteomics and metal ion profiling
CysMP-based metalloproteomics enables metal ion-specific profiling of proteomes and has revealed copper-regulated PGK1 activity. Mass spectrometry-based approaches identify copper-binding proteins and quantify metal occupancy. These methods are essential for discovering new copper-binding proteins and for understanding metal-specific effects.
Spectroscopic and biophysical assays
UV-visible spectroscopy, EPR, and fluorescence quenching are used to measure copper binding affinity and redox behavior. Isothermal titration calorimetry and circular dichroism provide thermodynamic and structural information. These assays are often combined with mutagenesis to map copper-binding residues.
Functional assays for copper-dependent processes
Amyloid formation assays, viral inactivation assays, and glycolytic activity measurements link copper binding to function. DNA degradation assays can test the activity of copper-bound porin fragments. These functional readouts complement structural and proteomic data.
How CRISPR Can Be Used to Study GO:0005507 copper ion binding
Knockout
CRISPR knockout of genes encoding copper-binding proteins such as SNCA, CRYAB, or PGK1 allows researchers to test whether copper ion binding is required for specific cellular functions. Knockout models can reveal loss-of-function phenotypes in metal homeostasis, amyloid formation, and metabolism. These models are essential for establishing causality between copper binding and downstream biology.
Point Mutation
Point mutations that alter copper-coordinating residues (e.g., histidine or cysteine) can selectively abolish copper binding without deleting the entire protein. Such models are critical for distinguishing copper-dependent from copper-independent functions. They also help validate structural models of copper-binding sites.
Knock-in
Knock-in of disease-associated or metal-binding site variants enables study of copper binding in a physiological context. For example, knock-in of α-synuclein variants can test how altered copper binding affects aggregation. Knock-in models are also useful for studying bacterial chaperone variants that adapt to different metals.
Overexpression
Overexpression of copper-binding proteins such as αB-crystallin or PGK1 can reveal gain-of-function effects and copper-dependent phenotypes. Overexpression models are particularly useful when the protein of interest is normally low-abundance. Combined with copper supplementation or chelation, these models can dissect copper-specific effects.
How EDITGENE Supports copper ion binding Research
Researchers studying copper ion binding-related genes often need to determine whether a candidate gene is causally involved in metal handling, aggregation, or metabolism. CRISPR-based models provide a direct way to test the function of copper-binding proteins by deleting, mutating, or tagging the relevant genes. EDITGENE offers a comprehensive suite of services to support these studies, from knockout and point-mutation cell lines to overexpression and library screening.
Contact EDITGENE today to design your custom CRISPR model for copper ion binding research.
Frequently Asked Questions About copper ion binding
What is GO:0005507 copper ion binding?
GO:0005507 is a molecular function term defined as binding to a copper (Cu) ion, with synonyms copper binding and copper/cadmium binding.
What genes are involved in copper ion binding?
Genes include SNCA, CRYAB, SILF, PGK1, ATP7A, ATP7B, SOD1, and metallothioneins such as MT1A and MT2A.
How does copper bind to α-synuclein?
Copper incorporates into α-synuclein amyloids, and this binding can influence amyloid structure and stability.
Does potassium affect copper binding to αB-crystallin?
Yes, potassium homeostasis influences copper ion binding to human αB-Crystallin.
What is the cupredoxin fold?
The cupredoxin fold is a protein scaffold that binds copper for electron transfer, with variations tuning its properties.
How is copper ion binding studied?
It is studied using structural biology, metalloproteomics such as CysMP, spectroscopy, and functional assays.
Can copper inactivate viruses?
Copper ion-catalyzed inactivation of human norovirus has been demonstrated, suggesting antiviral applications.
What is the role of SilF in copper binding?
SilF is a periplasmic chaperone with an adaptable Ag(I)/Cu(I) binding site involved in metal resistance.
How does copper regulate glycolysis?
Metalloproteomic studies show copper-regulated PGK1 activity in glycolysis.
Can cadmium compete with copper for binding?
Yes, cadmium can compete with copper at some binding sites, as shown with histidine-rich ligands.
Conclusion
Copper ion binding (GO:0005507) is a central molecular function that connects metal chemistry to diverse biological processes, from amyloid formation and chaperone function to bacterial metal resistance and antiviral mechanisms. The breadth of proteins annotated with this term, including α-synuclein, αB-crystallin, cupredoxin-fold proteins, SilF, and PGK1, highlights its importance across species and disease contexts. Continued research using structural biology, metalloproteomics, and CRISPR-based models will clarify how copper binding is regulated and how it can be targeted therapeutically.
References
- 1. Walke G et al.. 2024. Copper ion incorporation in α-synuclein amyloids.. Protein Sci 33(4):e4956 PMID: 38511511
- 2. Moosavi-Movahedi F et al.. 2024. Exploring the significance of potassium homeostasis in copper ion binding to human αB-Crystallin.. Int J Biol Macromol 263(Pt 1):130261 PMID: 38368978
- 3. Guo J et al.. 2022. Orchestrating copper binding: structure and variations on the cupredoxin fold.. J Biol Inorg Chem 27(6):529-540 PMID: 35994119
- 4. Yuan Y et al.. 2025. CysMP reveals metal ion-specific metalloproteomes and copper-regulated PGK1 activity in glycolysis.. Sci Adv 11(42):eadx7035 PMID: 41105763
- 5. Lithgo RM et al.. 2023. The adaptability of the ion-binding site by the Ag(I)/Cu(I) periplasmic chaperone SilF.. J Biol Chem 299(11):105331 PMID: 37820867
- 6. Stokowa-Sołtys K et al.. 2021. Effect of Copper(II) Ion Binding by Porin P1 Precursor Fragments from Fusobacterium nucleatum on DNA Degradation.. Int J Mol Sci 22(22) PMID: 34830424
- 7. Mertens BS et al.. 2022. Efficacy and Mechanisms of Copper Ion-Catalyzed Inactivation of Human Norovirus.. ACS Infect Dis 8(4):855-864 PMID: 35315654
- 8. Kolozsi A et al.. 2009. Copper(II) and zinc(II) ion binding properties of a MAP type branched ligand with histidines as surface functionalities.. Dalton Trans PMID: 20449077
